Plus   Neg

Merck KGaA Q2 Group Sales Up 3.7%

Merck KgaA (MKGAY.PK) reported a 3.7% growth in second-quarter sales, and said it now expects fiscal 2020 earnings of €5.60 - €6.25 per share pre, and group sales between €16.9 billion and €17.7 billion.

In addition, Merck has raised the lower end of the range for expected EBITDA pre and now forecasts a value between €4.45 billion and €4.85 billion.

The company's second-quarter net income fell by 38.5% to €290 million, and earnings per share pre declined 15.6% to €1.30.

"Despite considerable pandemic-related obstacles in some businesses, overall we did well in the second quarter. In recent months, we again proved the strengths of our diversified business model with three strong, innovation-driven business sectors," explained Stefan Oschmann, Chairman of the Executive Board and CEO of Merck.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT